Literature DB >> 6764378

Macrophages and neoplasms: new insights and their implication in tumor immunobiology.

R Evans.   

Abstract

In this review, I have attempted to draw together some recent findings of current importance in tumor-macrophage interactions. The widespread distribution of macrophages through the body, the ease of monocyte mobilization to inflammatory sites, the exquisite synthetic machinery of the macrophage and its potent antitumor activity, when this can be evoked by nonspecific means, imply a critical role for cells of this lineage in regulation and control of the neoplastic state. These new insights into the immunobiology of the macrophage revive our hopes both for a keener understanding of the complexity existing between the host and its neoplasm and for the development of successful therapies based on scientifically proven rationales.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6764378     DOI: 10.1007/bf00046829

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  70 in total

1.  Prostaglandins and cancer.

Authors:  G C Easty; D M Easty
Journal:  Cancer Treat Rev       Date:  1976-12       Impact factor: 12.111

2.  Post-mitotic age of monocuclear cells migrating into TA-3(St) solid tumors.

Authors:  L Kaizer; P K Lala
Journal:  Cell Tissue Kinet       Date:  1977-05

3.  Endotoxin and double stranded RNA render macrophages cytotoxic.

Authors:  P Alexander; R Evans
Journal:  Nat New Biol       Date:  1971-07-21

4.  Enhancement of anti-cancer activity of cytotoxic chemotherapy with protection of normal tissues by inhibition of P.G. synthesis.

Authors:  T J Powles; P Alexander; J L Millar
Journal:  Biochem Pharmacol       Date:  1978-05-01       Impact factor: 5.858

5.  Macrophage content and immunogenicity of C57BL/6J and BALB/cByJ methylcholanthrene-induced sarcomas.

Authors:  R Evans; E M Lawler
Journal:  Int J Cancer       Date:  1980-12-15       Impact factor: 7.396

6.  Adriamycin-activated macrophages as tumor growth inhibitors.

Authors:  J S Haskill
Journal:  Cancer Res       Date:  1981-10       Impact factor: 12.701

7.  Concurrent depression of tumor macrophage infiltration and systemic inflammation by progressive cancer growth.

Authors:  S J Normann; J Cornelius
Journal:  Cancer Res       Date:  1978-10       Impact factor: 12.701

8.  Macrophage-mediated tumor cell killing: lack of dependence on the cyclooxygenase pathway of prostaglandin synthesis.

Authors:  J O Shaw; S W Russell; M P Printz; R A Skidgel
Journal:  J Immunol       Date:  1979-07       Impact factor: 5.422

9.  Macrophage-mediated, antibody-dependent destruction of tumor cells in DBA/2 mice: in vitro identification of an in situ mechanism.

Authors:  M Key; S Haskill
Journal:  J Natl Cancer Inst       Date:  1981-01       Impact factor: 13.506

10.  Induction of fibroblast chemotaxis by fibronectin. Localization of the chemotactic region to a 140,000-molecular weight non-gelatin-binding fragment.

Authors:  A E Postlethwaite; J Keski-Oja; G Balian; A H Kang
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

View more
  12 in total

1.  Spindle cell haemangioendothelioma: probably a benign vascular lesion not a low-grade angiosarcoma. A clinicopathological, ultrastructural and immunohistochemical study.

Authors:  J Ding; H Hashimoto; S Imayama; M Tsuneyoshi; M Enjoji
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

2.  Effects of L2C leukemia on macrophage-mediated responses.

Authors:  D P Collins
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

3.  Immunoregulating activity of tumor-associated macrophages.

Authors:  G J Dougherty; W H McBride
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

4.  Growth-stimulating phase of macrophage response to activation: the phenomenon and its implications for tumour growth and immunotherapy.

Authors:  V B Okulov; B O Voytenkov; A G Ushmorov; N D Polischuk; S A Gromov
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

5.  Interaction of high or low metastatic related tumor lines with normal or lymphokine-activated syngeneic peritoneal macrophages: in vitro analysis of tumor cell binding and cytostasis.

Authors:  V Schirrmacher; B Appelhans
Journal:  Clin Exp Metastasis       Date:  1985 Jan-Mar       Impact factor: 5.150

Review 6.  Relationship of tumor leucocytic infiltration to host defense mechanisms and prognosis.

Authors:  J W Kreider; G L Bartlett; B L Butkiewicz
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

7.  Changes in the macrophage content of lung metastases at different stages in tumor growth.

Authors:  P J Bugelski; R L Kirsh; J M Sowinski; G Poste
Journal:  Am J Pathol       Date:  1985-03       Impact factor: 4.307

8.  Characterization of cells containing factor XIII subunit a in benign and malignant buccal lesions.

Authors:  M Toida; Y Okumura; K K Swe Win; N Oka; T Takami; R Adány
Journal:  Histochem J       Date:  1995-06

9.  A gelatin sponge model for studying tumor growth: quantitation of tumor cells and leukocytes in the CHO tumor.

Authors:  E T Akporiaye; G C Saunders; P M Kraemer
Journal:  Experientia       Date:  1987-06-15

10.  Different patterns of macrophage infiltration into allogeneic-murine and xenogeneic-human neoplasms growing in nude mice.

Authors:  C D Bucana; A Fabra; R Sanchez; I J Fidler
Journal:  Am J Pathol       Date:  1992-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.